Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin therapy to reduce critical illness polyneuropathy and myopathy in pediatric ICU
IRCT201108117295N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of human insulin in Critical Illness Polyneuropathy (CIP) and acute quadriplegic myopathy (CIM), sponsored by Tabriz University of Medical Sciences. Started Sep 2010; status: completed.
02
Drugs
human insulin
03
Conditions
Critical Illness Polyneuropathy (CIP)acute quadriplegic myopathy (CIM)
Beyond the preview
Go deeper on IRCT201108117295N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201108117295N1.